Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Vosevi
Voxilaprevir
Gilead
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 257
2018 Revenue in Millions : 396
Growth (%) : -35
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF